German open label trial of riluzole 50 mg b.i.d. in treatment of amyotrophic lateral sclerosis (ALS)

Journal of the Neurological Sciences

Volumn 180, Issue 1-2, 2000, Pages 82-85

  Pongratz, Dieter ^a   Neundörfer, Bernhard ^b   Fischer, Wilhelm ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Adverse events; Amyotrophic lateral sclerosis (ALS); Germany; Liver enzymes; Riluzole

Indexed keywords

LIVER ENZYME; RILUZOLE;

ABDOMINAL PAIN; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GERMANY; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG FUNCTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HUMANS; LIVER; MALE; MIDDLE AGED; RILUZOLE;

EID: 0034326760     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00426-3     Document Type: Article

References (18)

1. A controlled trial of riluzole in amyotrophic lateral sclerosis
2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis
3. Excitatory amino acid transmitters
4. Amino acids as dietary excitotoxins: A contribution to the understanding of neurodegenerative disorders
5. Altered glutamatergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: Possible role of glycine
6. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
7. Excitotoxicity and motor neuron disease: A review of the evidence
8. Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease
9. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis
10. The neuroprotective agent riluzole inhibits release of L-glutamate and L-aspartate from slices of hippocampal area CA1
11. 2-Amino-6-trifluoromethoxybenzothiazole, a possible antagonist of excitatory amino acid neurotransmission. Anticonvulsant properties
12. Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices
13. Neuroprotective effects of riluzole in ALS CSF toxicity
14. Riluzole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis
15. Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-(3H)aspartate release from cultured cerebellar granule cells
16. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed by Xenopus oocytes
17. Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: Evidence for a dual mechanism of action
18. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis